tiprankstipranks
Trending News
More News >
Sellas Life Sciences Group (SLS)
NASDAQ:SLS

Compare SELLAS Life Sciences Group (SLS) vs. Competitors

Compare
1,305 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
SELLAS Life Sciences Group
$4.11
$626.75M
238.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Galectin Therapeutics
$5.71
$203.11M
-5.21
150.41%
1 Buy
0 Hold
0 Sell
Moderate Buy
Voyager Therapeutics
$3.97
$219.06M
-1.83
-29.11%
7 Buy
0 Hold
0 Sell
Strong Buy
Tiziana Life Sciences
$1.37
$202.05M
-14.09
126.76%
Diamedica Therapeutics
$8.44
$456.20M
-11.77
41.85%
5 Buy
0 Hold
0 Sell
Strong Buy
Black Diamond Therapeutics
$2.59
$147.57M
7.08
4.05%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SLS
SELLAS Life Sciences Group
3.97
2.64
198.12%
GALT
Galectin Therapeutics
3.08
1.83
146.40%
VYGR
Voyager Therapeutics
3.97
-1.64
-29.23%
TLSA
Tiziana Life Sciences
1.61
0.92
133.33%
DMAC
Diamedica Therapeutics
8.44
2.59
44.27%
BDTX
Black Diamond Therapeutics
2.57
0.05
1.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts